These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11238792)

  • 21. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
    Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
    Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence?
    Thomas W; Speer CP
    Neonatology; 2008; 94(3):150-9. PubMed ID: 18679037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?
    Lodha A; Ediger K; Rabi Y; Lodha S; Tang S; Bhandari A; Sauve R; Bhandari V
    J Perinatol; 2015 Jul; 35(7):530-6. PubMed ID: 25719546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice.
    Thomas W; Speer CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):264-77. PubMed ID: 17582275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen and oxidative stress in bronchopulmonary dysplasia.
    Saugstad OD
    J Perinat Med; 2010 Nov; 38(6):571-7. PubMed ID: 20807008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired pulmonary vascular development in bronchopulmonary dysplasia.
    Baker CD; Abman SH
    Neonatology; 2015; 107(4):344-51. PubMed ID: 26044102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oxidant injury in the pathogenesis of neonatal lung disease.
    Davis JM
    Acta Paediatr Suppl; 2002; 91(437):23-5. PubMed ID: 12200893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia.
    Baveja R; Christou H
    Semin Perinatol; 2006 Aug; 30(4):209-18. PubMed ID: 16860161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current strategies for treating infants with severe bronchopulmonary dysplasia.
    Papoff P; Cerasaro C; Caresta E; Barbàra CS; Midulla F; Moretti C
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():15-20. PubMed ID: 23016612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in Bronchopulmonary Dysplasia: Pathophysiology, Prevention, and Treatment.
    Hwang JS; Rehan VK
    Lung; 2018 Apr; 196(2):129-138. PubMed ID: 29374791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventilatory management and bronchopulmonary dysplasia in preterm infants.
    Gupta S; Sinha SK; Donn SM
    Semin Fetal Neonatal Med; 2009 Dec; 14(6):367-73. PubMed ID: 19766071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bronhopulmonary dysplasia].
    Farstad T; Bratlid D
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2374-7. PubMed ID: 17895942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchopulmonary Dysplasia Within and Beyond the Neonatal Unit.
    Khetan R; Hurley M; Spencer S; Bhatt JM
    Adv Neonatal Care; 2016 Feb; 16(1):17-25;quiz E1-2. PubMed ID: 26734814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchopulmonary dysplasia.
    Deakins KM
    Respir Care; 2009 Sep; 54(9):1252-62. PubMed ID: 19712501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchopulmonary dysplasia.
    Kinsella JP; Greenough A; Abman SH
    Lancet; 2006 Apr; 367(9520):1421-31. PubMed ID: 16650652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An experimental animal model of bronchopulmonary dysplasia: Secondary publication.
    Namba F
    Pediatr Int; 2021 May; 63(5):504-509. PubMed ID: 33465831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD?
    Saugstad OD
    Acta Paediatr; 1997 Dec; 86(12):1277-82. PubMed ID: 9475300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current therapy of bronchopulmonary dysplasia.
    Rush MG; Hazinski TA
    Clin Perinatol; 1992 Sep; 19(3):563-90. PubMed ID: 1526072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.